Managing Partner, Harris Kaplan, published in PharmExec: Your Phase III Clinical Protocol Is Your Initial Product Launch
- Jan 30
- 1 min read

Harris Kaplan, Managing Partner, just published an article in Pharma Executive, Your Phase III Clinical Protocol Is Your Initial Product Launch.
Phase III clinical protocols do more than satisfy regulators. They determine what a product can claim, how it will be valued, and whether it can truly compete at launch. Drawing on real-world experience, Harris'
article examines why commercial success is often decided years before a product reaches patients.

